OPKO Health Europe is a division of OPKO Health Inc., a multinational biopharmaceutical and diagnostics company with over 25 years of experience. The company focuses on improving quality of life through innovative health management solutions. Its mission is to promote wellness and continuous health improvement by developing advanced pharmaceutical and diagnostic products aimed at well-being and longevity.

Operating in various countries, including Spain, Chile, and Brazil, OPKO Health Europe employs over 1,000 people and markets more than 500 products globally. The company offers a diverse portfolio that includes medications like Rayaldee, NGENLA, and Varubi, as well as advanced diagnostic solutions such as molecular tests and point-of-care technologies. Their U.S.-based BioReference Laboratories is one of the largest clinical reference labs, serving millions of patients each year.

Targeting healthcare providers, OPKO Health Europe aims to enhance treatment outcomes and health management for patients with serious diseases. The company is committed to innovation and teamwork, striving to be recognized as a leader in health technology and longevity products.